Bone formation is a carefully controlled developmental process involving morphogen-mediated patterning signals that define areas of initial mesenchyme condensation followed by induction of cell-specific differentiation programs to produce chondrocytes and osteoblasts. Positional information is conveyed via gradients of molecules, such as Sonic Hedgehog that are released from cells within a particular morphogenic field together with region-specific patterns of hox gene expression. These, in turn, regulate the localized production of bone morphogenetic proteins and related molecules which initiate chondrocyte- and osteoblast-specific differentiation programs. Differentiation requires the initial commitment of mesenchymal stem cells to a given lineage, followed by induction of tissue-specific patterns of gene expression. Considerable information about the control of osteoblast-specific gene expression has come from analysis of the promoter regions of genes encoding proteins like osteocalcin that are selectively expressed in bone. Both general and tissue-specific transcription factors control this promoter. Osf2/Cbfal, the first osteoblast-specific transcription factor to be identified, is expressed early in the osteoblast lineage and interacts with specific DNA sequences in the osteocalcin promoter essential for its selective expression in osteoblasts. The OSF2/CBFA1 gene is necessary for the development of mineralized tissues, and its mutation causes the human disease, cleidocranial dysplasia. Committed osteoprogenitor cells already expressing Osf2/Cbfa1 must synthesize a collagenous ECM before they will differentiate. A ceII:ECM interaction mediated by integrin-type cell-surface receptors is essential for the induction of osteocalcin and other osteoblast-related proteins. This interaction stimulates the binding of Osf2/Cbfa 1 to the osteocalcin promoter through an as-yet-undefined mechanism.
References
1.
Ahn MY, Bae SC, Maruyama M., Ito Y. (1996). Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family. Gene168:279-280.
2.
Asahina I., Sampath TK, Nishimura I., Hauschka PV (1993). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol123:921-933.
3.
Aubin J., Lui F. (1996). The osteoblast lineage. In: Principles of bone biology. Bilezikian LGRJP, Rodan GA, editors. San Diego, CA: Academic Press, pp. 51-67.
4.
Banerjee C., Hiebert SW, Stein JL, Lian JB, Stein GS (1996). An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA93:4968-4973.
5.
Banerjee C., McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, et al. (1997). Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem66:1-8.
6.
Bellahcene A., Kroll M., Liebens F., Castronovo V. (1996). Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res11:665-670.
7.
Benezra R., Davis RL, Lockshon D., Turner DL, Weintraub H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell61:49-59.
8.
Benson M., Decker J., Cui Y., Tirasophon W., Franceschi R. (1995). Osteoblast basic helix-loop-helix proteins: regulation of the Id family and use of the two-hybrid system to identify novel factors (abstract). J Bone Miner Res10:S314.
9.
Benson M., Cui Y., Aubin J., Franceschi R. (1997). Cloning and analysis of a 2.5 kb murine bone sialoprotein promoter fragment exhibiting osteoblast-restricted expression (abstract). J Bone Miner Res12:S277.
10.
Bianco P., Fisher LW, Young MF, Termine JD, Gehron-Robey P. (1991). Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int49:421-426.
11.
Bidwell JP, Van Wijnen A.], Fey EG, Dworetzky S., Penman S., Stein JL, et al. (1993). Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci USA90:3162-3166.
12.
Blanco JC, Wang IM, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, et al. (1995). Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA92:1535-1539.
13.
Boden SD, Hair G., Titus L., Racine M., McCuaig K., Wozney JM, et al. (1997). Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology138:2820-2828.
14.
Bornstein P. (1996). Regulation of expression of the alpha 1 (I) collagen gene: a critical appraisal of the role of the first intron [see comments Matrix Biol 15:3-10.
15.
Bronckers AL, Gay S., Finkelman RD, Butler WT (1987). Immunolocalization of Gla proteins (osteocalcin) in rat tooth germs: comparison between indirect immunofluorescence, peroxidase-antiperoxidase, avidin-biotin-peroxidase complex, and avidin-biotin-gold complex with silver enhancement. J Histochem Cytochem35:825-830.
16.
Chen J., McCulloch CA, Sodek J. (1993). Bone sialoprotein in developing porcine dental tissues: cellular expression and comparison of tissue localization with osteopontin and osteonectin. Arch Oral Biol38:241-249.
17.
Chen J., Thomas HF, Jin H., Jiang H., Sodek J. (1996). Expression of rat bone sialoprotein promoter in transgenic mice. J Bone Miner Res11:654-664.
18.
Chen Y., Bei M., Woo I., Satokata I., Maas R. ( 1996). Msx1 controls inductive signaling in mammalian tooth morphogenesis. Development122:3035-3044.
19.
Clark EA, Brugge IS (1995). Integrins and signal transduction pathways: the road taken. Science268:233-239.
20.
Clemens TL, Tang H., Maeda S., Kesterson RA, DeMayo J., Pike JW, et al. (1997). Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J Bone Miner Res12:1570-1576.
21.
Clover 1, Dodds R., Gowen M. (1992). Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J Cell Sci103:267-271.
22.
Cserjesi P., Brown D., Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, et al. (1995). Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development121:1099-1110.
23.
D'Errico J., MacNeil R., Takata T., Berry J., Strayhorn C., Somerman M. (1997). Expression of bone associated markers by tooth root lining cells, in situ and in vitro. Bone20:117-126.
24.
Desbois C., Hogue DA, Karsenty G. (1994). The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem269:1183-1190.
25.
Dodig M., Kronenberg M., Bedalov A., Kream B., Gronowicz G., Clark S., et al. (1996a). Identifiction of a TAAT-containing motif required for high level expression of the COLIAI promoter in differentiated osteoblasts of transgenic mice. J Biol Chem271:16422-16429.
26.
Dodig M., Kronenberg MS, Bedalov A., Kream BE, Gronowicz G., Clark SH, et al. (1996b). Identification of a TAAT-containing motif required for high level expression of the COLIAI promoter in differentiated osteoblasts of transgenic mice. J Biol Chem271:16422-16429.
27.
Ducy P., Karsenty G. (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol15:1858-1869.
28.
Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. (1996). Increased bone formation in osteocalcin-deficient mice. Nature382:448-452.
29.
Ducy P., Zhang R., Geoffroy V., Ridall AL, Karsenty G. (1997). Osf2/Cbfa 1: a transcriptional activator of osteoblast differentiation. Cell89:747-754.
30.
Erlebacher A., Filvaroff EH, Gitelman SE, Derynck R. (1995). Toward a molecular understanding of skeletal development [comment]. Cell80:371-378.
31.
Fedarko NS, Moerike M., Brenner R., Robey PB (1992). Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res7:921-930.
32.
Fedarko NS, Sponseller PD, Shapiro JR (1996). Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts. J Bone Miner Res11:800-805.
33.
Franceschi RT (1992). The role of ascorbic acid in mesenchymal differentiation. Nutr Rev50:65-70.
34.
Franceschi RT, lyer BS ( 1992). Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res7:235-246.
35.
Franceschi RT, Romano PR, Park KY ( 1988). Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. ) J Biol Chem263:18938-18945.
36.
Franceschi RT, lyer BS, Cui Y. (1994). Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res9:843-854.
37.
Frendo J.-L, Xiao G., Fuchs S., Franceschi RT, Karsenty G., Ducy P. ( 1998). Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J Biol Chem273:30509-30516.
38.
Friedenstein A.), Chailakhyan RK, Gerasimov UV (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet20:263-272.
39.
Gendron-Maguire M., Mallo M., Zhang M., Grindley T. (1993). Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell75:1317-1331.
40.
Geoffroy V., Ducy P., Karsenty G. (1995). A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem270:30973-30979.
41.
Gergen J., Wieschaus E. (1985). The localized requirements for a gene affecting segmentation in Drosophila: analysis of larvae mosaic for runt. Dev Biol109:321-335.
42.
Gerstenfeld LC, Chipman SD, Glowacki J., Lian JB ( 1987). Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol122:49-60.
43.
Gerstenfeld LC, Zurakowski D., Schaffer JL, Nichols DP, Toma CD, Broess M., et al. (1996). Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineage. Endocrinology137:3957-3968.
44.
Gitelman SE, Kirk M., Ye JQ, Filvaroff EH, Kahn AJ, Derynck R. (1995). Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ6:827-836.
45.
Grigoriadis AE, Heersche JN, Aubin JE (1988). Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. I Cell Biol106:2139-2151.
46.
Gronowicz GA, Derome ME (1994). Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res9:193-201.
47.
Gronthos S., Graves SE, Ohta S., Simmons P.) (1994). The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood84:4164-4173.
48.
Grzesik WJ, Gehron-Robey P. (1994). Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. I Bone Miner Res9:487-496.
49.
Gumbiner BM (1996). Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell84:345-357.
50.
Heimrika-Wagner AM, Bronckers ALJJ, Woltgens JHM (1982). Ultrastructural changes in developing hamster molars during vitamin C deficiency in vitro. J Biol Buccale10:163-173.
51.
Heinrichs AA, Bortell R., Bourke M., Lian JB, Stein GS, Stein JL (1995). Proximal promoter binding protein contributes to developmental, tissue-restricted expression of the rat osteocalcin gene. J Cell Biochem57:90-100.
52.
Hodgkinson JE, Davidson CL, Beresford J., Sharpe PT (1993). Expression of a human homeobox-containing gene is regulated by 1,25(OH)2D3 in bone cells. Biochim Biophys Acta1174:11-16 [published erratum appears in Biochim Biophys Acta 1216:173, 1993].
53.
Hughes D., Salter S., Dedhar S., Simpson R. (1993). Integrin expression in human bone. J Bone Miner Res8:527-533.
54.
Hunter GK, Goldberg HA (1993). Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA90:8562-8565.
55.
Ibaraki K., Termine JD, Whitson SW, Young MF (1992). Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res7:743-754.
56.
Ingraham HA, Albert VR, Chen RP, Crenshaw EB 3rd, Elsholtz HP, He X., et al. (1990). A family of POUdomain and Pit- I tissue-specific transcription factors in pituitary and neuroendocrine development. Ann Rev Physiol52:773-791.
57.
Jabs EW, Muller U., Li X., Ma L., Luo W., Haworth IS, et al. (1993). A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell75:443-450.
58.
Johnson RL, Tabin C.) (1997). Molecular models for vertebrate limb development. Cell90:979-990.
59.
Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol127:1755-1766 [published erratum appears in J Cell Biol128(4):following 713, 1995].
60.
Kerner SA, Scott RA, Pike JW ( 1989). Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA86:4455-4459.
61.
Kerr JM, Fisher LW, Termine JD, Wang MG, McBride OW, Young MF (1993). The human bone sialoprotein gene (IBSP): genomic localization and characterization. Genomics17:408-415.
62.
Kesterson RA, Stanley L., DeMayo F., Finegold M., Pike JW ( 1993). The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice. Mol Endo7:462-467.
63.
Kim RH, Shapiro HS, Li JJ, Wrana JL, Sodek J. (1994). Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence. Matrix Biol14:31-40.
64.
Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. (1997). Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comments]. Cell89:755-764.
65.
Lee B., Thirunavukkarasu K., Zhou L., Pastore L., Baldini A., Hecht J., et al. (1997). Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet16:307-310.
66.
Lee JE, Hollenberg SM, Snider L., Turner DL, Lipnick N., Weintraub H. (1995). Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science268:836-844.
67.
Lesot H., Smith A., Tziafas D., Begue-Kirn C., Cassidy N., Ruch J. ( 1994). Biologically active molecules and dental tissue repair: a comparative review of reactionary and reparative dentinogenesis with the induction of odontoblast differentiation in vitro. Cells Mater4:199-218.
68.
Li JJ, Sodek J. (1993). Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem J289:625-629.
69.
Lian J., Stewart C., Puchacz E., Mackowiak S., Shalhoub V., Collart D., et al. (1989). Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA86:1143-1147.
70.
Lian JB, Shalhoub V., Aslam F., Frenkel B., Green J., Hamrah M., et al. (1997). Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-EI osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology138:2117-2127.
71.
Lin TH, Aplin AE, Shen Y., Chen Q., Schaller M., Romer L., et al. (1997). lntegrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol136:1385-1395.
72.
MacDougall M., Simmons D., Luan X., Nydegger J., Feng J., Gu TT (1997). Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. J Biol Chem272:835-842.
73.
MacNeil RL, Somerman MI (1993). Molecular factors regulating development and regeneration of cementum. J Periodont Res28:550-559.
Mahmoodian F., Gosiewska A., Peterkofsky B. (1996). Regulation and properties of bone alkaline phosphatase during vitamin C deficiency in guinea pigs. Arch Biochem Biophys336:86-96.
76.
Markose ER, Stein JL, Stein GS, Lian JB ( 1990). Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA87:1701-1705.
77.
McCabe LR, Kockx M., Lian J., Stein J., Stein G. (1995). Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res218:255-262.
78.
McCauley LK, Koh AJ, Beecher CA, Cui Y., Rosol TJ, Franceschi RT (1996). PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis. J Cell Biochem61:638-647.
79.
Merriman HL, van Wijnen AJ Hiebert S., Bidwell JP, Fey E., Lian J., et al. (1995). The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry34:13125-13132.
80.
Meyers S., Downing JR, Hiebert SW (1993). Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol13:6336-6345.
81.
Montecino M., Pockwinse S., Lian J., Stein G., Stein J. (1994). DNase I hypersensitive sites in promoter elements associated with basal and vitamin D dependent transcription of the bone-specific osteocalcin gene. Biochemistry33:348-353.
Murray SS, Glackin CA, Winters KA, Gazit D., Kahn AJ, Murray EJ (1992). Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J Bone Miner Res7:1131-1138.
84.
Murray SS, Murray EJ, Glackin CA, Urist MR (1993). Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells. J Cell Biochem53:51-60.
85.
Nickerson JA, Blencowe BJ, Penman S. (1995). The architectural organization of nuclear metabolism. Int Rev Cytol162(A):67-123.
86.
Nishiyori A., Tashiro H., Kimura A., Akagi K., Yamamura K., Mori M., et al. (1994). Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. Both HNF-4 and C/EBP beta are required for liver-specific activity of the ornithine transcarbamylase enhancer. J Biol Chem269:1323-1331.
87.
Ogata T., Noda M. ( 1991) Expression of Id, a negative regulator of helix-loop-helix DNA binding proteins, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1. Biochem Biophys Res Commun180:1194-1199.
88.
Ogata T., Wozney JM, Benezra R., Noda M. ( 1993) Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA90:9219-9222.
89.
Ogata Y., Yamauchi M., Kim RH, Li JJ, Freedman LP, Sodek J. (1995). Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem230:183-192.
90.
Oldberg A., Franzen A., Heinegard D. (1986). Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA83:8819-8823.
91.
Olson EN, Klein WH (1994). bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev8:1-8.
92.
Otto F., Thornell AP, Crompton T., Denzel A., Gilmour KC, Rosewell IR, et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development [see comments]. Cell89:765-771.
93.
Owen TA, Aronow M., Shalhoub V., Barone LM, Wilming L., Tassinari MS, et al. (1990). Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol143:420-430.
94.
Quarles LD, Yohay DA, Lever LW, Caton R., Wenstrup RJ (1992). Distinct proliferative and differentiated stages of murine MC3T3-E 1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res7:683-692.
95.
Quarles LD, Siddhanti SR, Medda S. (1997). Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elements. J Cell Biochem65:11-24.
96.
Riikonen T., Westermarck J. Koivisto L., Broberg A., Kahari VM, Heino J. (1995). lntegrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1 (1) gene expression. J Biol Chem270:13548-13552.
97.
Roeckel D., Krieg T. (1994). Three-dimensional contact with type I collagen mediates tyrosine phosphorylation in primary human fibroblasts. Exp Cell Res211:42-48.
98.
Saito T., Albelda SM, Brighton CT (1994). Identification of integrin receptors on cultured human bone cells. I Orthop Res12:384-394.
99.
Sasaki K., Yagi H., Bronson RT, Tominaga K., Matsunashi T., Deguchi K., et al. (1996). Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci USA93:12359-12363.
100.
Satokata I., Maas R. ( 1994). Msxl deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development [see comments]. Nat Genet6:348-356.
101.
Schiro JA, Chan BM, Roswit WT, Kassner PD, Pentland AP, Hemler ME, et al. (1991). Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell67:403-410.
102.
Schule R., Umesono K., Mangelsdorf DJ, Bolado J., Pike JW, Evans RM (1990). Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell61:497-504.
103.
Schwimmer R., Ojakian GK (1995). The alpha 2 beta I integrin regulates collagen-mediated MDCK epithelial membrane remodeling and tubule formation. J Cell Sci108:2487-2498.
104.
Shi S., Kirk M., Kahn AJ ( 1996). The role of type I collagen in the regulation of the osteoblast phenotype. J Bone Miner Res11:1139-1145.
105.
Sinha R., Tuan R. ( 1996). Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone18:451-457.
106.
Sodek J. Li JJ, Kim RH, Ogata Y., Yamauchi M., Zhang Q., et al. (1994). Steroid hormone regulation of bone sialoprotein gene transcription. In: The biological mechanisms of tooth eruption, resorption and replacement by implants. Davidovitch Z, editor. Boston: Harvard Society for the Advancement of Orthodontics, pp. 215-225.
107.
Sodek J., Kim RH, Ogata Y., Li J., Yamauchi M., Zhang Q., et al. (1995). Regulation of bone sialoprotein gene transcription by steroid hormones. Connect Tissue Res32:209-217.
108.
Sodek J., Li JJ, Kim RH, Ogata Y., Yamauchi M. (1996). Characterization of the bone sialoprotein (BSP) gene promoter. Connect Tissue Res35:23-31.
109.
Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA (1991). Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem266:7363-7367.
110.
Stein GS, Lian JB, Stein JL, van Wijnen A.), Frankel B., Montecino M. (1996). Mechanisms regulating osteoblast proliferation and differentiation. In: Principles of bone biology. Bilezikian LGRJP, Rodon GA, editors. San Diego, CA: Academic Press, pp. 69-86.
111.
Strauss PG, Closs EL, Schmidt J., Erfle V. (1990). Gene expression during osteogenic differentiation in mandibular condyles in vitro. J Cell Biol110:1369-1378.
112.
Sudbeck BD, Parks WC, Welgus HG, Pentland AP ( 1994). Collagen-stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities. J Biol Chem269:30022-30029.
113.
Suva LJ, Seedor JG, Endo N., Quartuccio HA, Thompson DD, Bab I., et al. (1993). Pattern of gene expression following rat tibial marrow ablation. I Bone Miner Res8:379-388.
114.
Takeuchi Y., Nakayama K., Matsumoto T. (1996). Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J Biol Chem271:3938-3944.
115.
Takeuchi Y., Suzawa M., Kikuchi T., Nishida E., Fujita T., Matsumoto T. (1997). Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha 2 beta 1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem272:29309-29316.
116.
Tamura M., Noda M. ( 1994). Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J Cell Biol126:773-782.
117.
Taylor SM, Jones PA (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell17:771-779.
118.
Thesleff 1, Vaahtokari A., Partanen AM (1995). Regulation of organogenesis. Common molecular mechanisms regulating the development of teeth and other organs. Int J Dev Biol39:35-50.
119.
Thies RS, Bauduy M., Ashton BA, Kurtzberg L., Wozney JM, Rosen V. (1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology130:1318-1324.
120.
Thirunavukkarasu K., Mahajan M., McLarren KW, Stifani S., Karsenty G. (1998). Two domains unique to osteoblast-specific transcription factor Osf2/Cbfal contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol Cell Biol15:1858-1869.
121.
Tickle C. (1995). Vertebrate limb development. Curr Opin Genet Dev5:478-484.
122.
Togari A., Arai M., Nakagawa S., Banno A., Aoki M., Matsumoto S. (1995). Alteration of bone status with ascorbic acid deficiency in ODS (osteogenic disorder Shionogi) rats. Jpn J Pharmacol68:255-261.
123.
Tontonoz P., Kim JB, Graves RA, Spiegelman BM (1993). ADDI: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol13:4753-4759.
124.
Towler DA, Rutledge SJ, Rodan GA (1994). MSX-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Mol Endo8:1484-1493.
125.
Triffit J. (1996). The stem cell of the osteoblasts. In: Principles of bone biology. Bilezikian LGRJP, Rodon GA, editors. San Diego, CA: Academic Press, pp. 539-550.
126.
Wang EA, Israel DI, Kelly S., Luxenberg DP (1993). Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors9:57-71.
127.
Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., et al. (1991). The myoD gene family: nodal point during specification of the muscle cell lineage. Science251:761-766.
128.
Wenstrup R.), Fowlkes JL, Witte DP, Florer IB (1996). Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrix. J Biol Chem271:10271-10276.
129.
Xiao G., Cui Y., Ducy P., Karsenty G., Franceschi RT (1997). Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endo11:1103-1113.
130.
Xiao G., Wang D., Benson MD, Karsenty G., Franceschi RT (1998a). Role of the α2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem273:32988-32994.
131.
Xiao G., Thomas PE, Jiang D., Benson MD, Franceschi RT (1998b). MEK/MAPK activates osteoblast-specific transcription factor, Osf2/Cbfal (abstract). Bone23:S150.
132.
Yang R., Gerstenfeld LC (1996). Signal transduction pathways mediating parathyroid hormone stimulation of bone sialoprotein gene expression in osteoblasts. I Biol Chem271:29839-29846.
133.
Yang R., Gerstenfeld LC (1997). Structural analysis and characterization of tissue and hormonal responsive expression of the avian bone sialoprotein (BSP) gene. J Cell Biochem64:77-93.
134.
Zeng C., van Wijnen AJ, Stein JL, Meyers S., Sun W., Shopland L., et al. (1997). Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci USA94:6746-6751.
135.
Zhang H., Hu G., Wang H., Sciavolino P., Iler N., Shen MM, et al. (1997). Heterodimerization of MSX and Dlx homeoproteins results in functional antagonism. Mol Cell Biol17:2920-2932.
136.
Zhang R., Ducy P., Karsenty G. (1997). 1,25-dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem272:110-116.
137.
Zimmerman D., Globus R., Damsky C. (1997). In vivo and in vitro models of altered integrin function in osteoblasts: effects on osteoblast maturation and bone remodeling (abstract). J Bone Miner Res12: S154.
